PulseAugur
EN
LIVE 23:20:26

Greater Manchester rejects NHS data platform with Palantir tech

By PulseAugur Editorial · [1 sources] ·

Greater Manchester's Integrated Care Board (ICB) has again rejected a proposed NHS data platform, citing ongoing public concerns and a lack of demonstrated benefits. The platform, which would utilize Palantir's technology, has faced significant opposition. The ICB noted that public apprehension has only intensified since the initial proposal. AI

IMPACT Minimal direct impact on AI operators; reflects public sector caution with AI-adjacent data platforms.

RANK_REASON This is a local government/public sector decision regarding the adoption of a specific technology platform, not a core AI release or significant industry-wide event.

Read on The Register — AI →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Greater Manchester rejects NHS data platform with Palantir tech

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
This is a local government/public sector decision regarding the adoption of a specific technology platform, not a core AI release or significant industry-wide event.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
policy, product
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
143 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. The Register — AI TIER_1 English(EN) ·

    Greater Manchester still says no to NHS data platform with Palantir at its heart

    Public concern has only grown, says ICB, while evidence of benefits remains thin

RELATED ENTITIES

RELATED TOPICS